Mario Negri Institute for Pharmacological Research, Via Giuseppe La Masa 19, Milan, Italy.
Eur J Cancer Prev. 2012 May;21(3):268-73. doi: 10.1097/CEJ.0b013e328350b11b.
The role of alcohol intake in the risk of Hodgkin lymphoma (HL) is still largely unclear. To summarize the evidence on the issue, we carried out a meta-analysis of the available studies. We identified eight case-control and two cohort studies, including a total of 1488 cases of HL. We derived meta-analytic estimates using random-effects models, taking into account the correlation between estimates, and carried out a dose-risk analysis using nonlinear random-effects metaregression models. Compared with nondrinkers, the relative risk for alcohol consumers was 0.70 [95% confidence interval (CI), 0.60-0.81] overall, 0.66 (95% CI, 0.56-0.78) among case-control, and 0.92 (95% CI, 0.63-1.33) among cohort studies. Compared with nondrinkers, the pooled relative risks were 0.71 (95% CI, 0.57-0.89) for light (i.e. ≤1 drink/day) and 0.73 (95% CI, 0.60-0.87) for moderate-to-heavy (i.e. >1 drink/day) alcohol drinking. This meta-analysis suggests a favourable effect of alcohol on HL, in the absence, however, of a dose-risk relationship. The inverse association was restricted to--or greater in--case-control as compared with cohort studies. This indicates caution in the interpretation of results.
饮酒在霍奇金淋巴瘤(HL)发病风险中的作用仍不清楚。为了总结该问题的现有证据,我们对可用的研究进行了荟萃分析。我们共纳入了 8 项病例对照研究和 2 项队列研究,共包含 1488 例 HL 病例。我们采用随机效应模型计算汇总估计值,同时考虑了估计值之间的相关性,并采用非线性随机效应荟萃回归模型进行剂量-风险分析。与不饮酒者相比,饮酒者的相对危险度为 0.70(95%置信区间 [CI]:0.60-0.81),病例对照研究中为 0.66(95%CI:0.56-0.78),队列研究中为 0.92(95%CI:0.63-1.33)。与不饮酒者相比,轻度饮酒(即≤1 份/天)和中重度饮酒(即>1 份/天)的汇总相对危险度分别为 0.71(95%CI:0.57-0.89)和 0.73(95%CI:0.60-0.87)。本荟萃分析提示酒精可能对 HL 具有保护作用,但无剂量-风险关系。病例对照研究中与队列研究相比,反比关系更为显著或更显著。这表明对结果的解释需要谨慎。